Chemoinformaics analysis of Robustone And 4-O-Methylalpinum Isoflavone
| Molecular Weight | 350.37 | nRot | 2 |
| Heavy Atom Molecular Weight | 332.226 | nRig | 23 |
| Exact Molecular Weight | 350.115 | nRing | 4 |
| Solubility: LogS | -3.331 | nHRing | 2 |
| Solubility: LogP | 4.848 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 44 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 26 | No. of Aromatic Carbocycles | 2 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 21 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 17 |
| nHA | 5 | APOL | 51.0823 |
| nHD | 1 | BPOL | 24.1337 |
| QED | 0.744 |
| Synth | 2.729 |
| Natural Product Likeliness | 1.987 |
| NR-PPAR-gamma | 0.98 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.992 |
| Pgp-sub | 0 |
| HIA | 0.012 |
| CACO-2 | -4.681 |
| MDCK | 0.00002 |
| BBB | 0.017 |
| PPB | 0.991962 |
| VDSS | 0.45 |
| FU | 0.0239496 |
| CYP1A2-inh | 0.893 |
| CYP1A2-sub | 0.787 |
| CYP2c19-inh | 0.931 |
| CYP2c19-sub | 0.074 |
| CYP2c9-inh | 0.91 |
| CYP2c9-sub | 0.932 |
| CYP2d6-inh | 0.819 |
| CYP2d6-sub | 0.882 |
| CYP3a4-inh | 0.663 |
| CYP3a4-sub | 0.202 |
| CL | 1.723 |
| T12 | 0.167 |
| hERG | 0.1 |
| Ames | 0.083 |
| ROA | 0.874 |
| SkinSen | 0.558 |
| Carcinogencity | 0.815 |
| EI | 0.108 |
| Respiratory | 0.801 |
| NR-Aromatase | 0.79 |
| Antiviral | Yes |
| Prediction | 0.897504 |